Page 12 - மனிதன் சேவைகள் அலுவலகம் ஆஃப் இன்ஸ்பெக்டர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Texas Medical Equipment Company Owners Convicted of $27M Fraud
insurancejournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancejournal.com Daily Mail and Mail on Sunday newspapers.
Cynthia Morton McKnight s Long Term Care News
mcknights.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mcknights.com Daily Mail and Mail on Sunday newspapers.
COVID-19 dealt a devasting blow to nursing homes — don t let looming cuts make it worse - Guest columns
mcknights.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mcknights.com Daily Mail and Mail on Sunday newspapers.
Published: 10 July 2021 10 July 2021
Dallas, Texas - A federal jury convicted Dallas area owners and operators of two durable medical equipment companies Thursday of one count of conspiracy to defraud the United States and to pay and receive health care kickbacks and one count of conspiracy to commit money laundering.
According to the evidence presented at trial, Leah Hagen, 49, and Michael Hagen, 54, of Arlington, Texas, were owners and operators of two durable medical equipment (DME) companies: Metro DME Supply LLC (Metro) and Ortho Pain Solutions LLC (Ortho Pain), both operated out of the same location in Arlington. The defendants paid a fixed rate per DME item in exchange for prescriptions and paperwork completed by telemedicine doctors that were used to submit false claims to Medicare. The defendants paid illegal bribes and kickbacks and wired money to their co-conspirator’s call center in the Philippines that provided signed doctor’s orders for orthotic braces. The ev
Sarah Silbiger/Getty Images North America/Getty Images
FDA Acting Commissioner Dr. Janet Woodcock requested an investigation by the US Department of Health and Human Services Office of Inspector General into the controversial approval of the Alzheimer s disease drug Aduhelm.
By Jamie Gumbrecht, CNN
US Food and Drug Administration Acting Commissioner Dr. Janet Woodcock on Friday requested an investigation by the US Department of Health and Human Services Office of Inspector General into the controversial approval of the Alzheimer’s disease drug Aduhelm.
In a letter posted on Twitter, Woodcock said an independent review and assessment should consider interactions between Biogen, the company that makes Aduhelm, and the FDA during the process that led to the June approval of the drug.